16.28

Sato, Yuichi; Matsumoto, Naoya; Yoda, Shunichi; Kunimasa, Taeko; Miki, Takeshi; Igarashi, Yasumi; Kato, Masataka; Nakano, Yoshimitsu; Kusama, Junji; Saito, Satoshi

doi:10.1016/j.nuclcard.2007.06.042

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is concern that noncalcified, nonobstructive plaques on MDCT may potentially represent vulnerable lesions. Sato et al (24) evaluated the prognostic value of low-density (Ͻ68 HU) plaques in nonobstructive (25% to 75%) coronary artery stenoses detected on MDCT in 810 consecutive patients. These lesions were identified in 189 patients.…”

Section: Asnc 2007mentioning

confidence: 99%

Imaging Highlights From the European Society of Cardiology, American Society of Nuclear Cardiology, and Heart Failure Society of America

Knuuti

Poldermans²,

Udelson

et al. 2008

JACC: Cardiovascular Imaging

View full text Add to dashboard Cite

show abstract

Section: Asnc 2007mentioning

confidence: 99%

Imaging Highlights From the European Society of Cardiology, American Society of Nuclear Cardiology, and Heart Failure Society of America

Knuuti

Poldermans²,

Udelson

et al. 2008

JACC: Cardiovascular Imaging

View full text Add to dashboard Cite

show abstract

“…Patients with a higher total cholesterol/high-density lipoprotein cholesterol ratio had a higher prevalence of proximal and significant CAD on CTA (20). Another CT study in more than 700 patients demonstrated that low-density plaques were independently predictive of the occurrence of an acute ischemic episode over a 3-year follow-up period (21). Another topic of interest is the radiation dosage associated with cardiac diagnostic testing, in particular cardiac CT. One study of the clinical experience with radiation sparing algorithms in coronary CTA revealed that by concerted effort the radiation dosage was dramatically reduced, whereas diagnostic quality remained good (22).…”

Section: Original Research: Abstract Contributionsmentioning

confidence: 99%

Highlights of the 2007 Scientific Sessions of the American Society of Nuclear Cardiology

Russell¹,

Abbott²,

Arrighi³

et al. 2007

Journal of the American College of Cardiology

View full text Add to dashboard Cite

The 12th annual Scientific Sessions of the American Society of Nuclear Cardiology (ASNC) (chaired by Dr. Brian Abbott) were held in San Diego, California, from September 6 through 9, 2007. The meeting, entitled "Cardiac Imaging: Imagine the Future," attracted over 1,700 attendees. The scientific sessions were structured along specifically designed tracks, including the technical, core, and advanced tracks focusing on nuclear cardiac imaging and a dedicated computed tomography (CT) track, addressing the growing role of CT in noninvasive cardiac imaging and its integration with nuclear techniques in hybrid cardiac imaging. These tracks were complemented by the plenary sessions, which included keynote speakers addressing the role of nuclear cardiology in the healthcare system. Original research was presented in abstract presentations and a Young Investigator Award competition. Plenary SessionsDr. Robert Bonow gave the sixth annual Mario Verani Memorial Lecture, which is presented each year at the ASNC annual meeting by a prominent nuclear cardiologist, in memory of Dr. Mario Verani (1943 to 2001, a pioneer in nuclear cardiology and founder and past president of the ASNC. Dr. Bonow pointed out the gains that have been made in the fight against cardiovascular disease in the U.S., with deaths due to coronary artery disease (CAD) declining since the 1970s. With this backdrop, he posed the question: What role does imaging play in improved outcomes? There has been a tremendous increase, on the basis of data from the Centers for Medicare and Medicaid Services and other sources, in the number of stress tests performed over the past 10 years, owing in large part to increases in myocardial perfusion imaging (MPI). With this increase comes an increase in cost, and Dr. Bonow asked whether this added cost provides added value. Cardiac imaging, mostly nuclear imaging and echocardiography at this point in time, has been shown to be useful for the diagnosis of CAD. In addition, there is a wealth of data, particularly regarding nuclear imaging, supporting the prognostic value of such tests. A normal study portends an excellent prognosis, whereas the prognosis becomes progressively worse with increasing degrees of abnormality of these tests. He noted, however, that all of the prognostic studies were retrospective, nonrandomized trials.

show abstract

16.28

Cited by 2 publications

References 0 publications

Imaging Highlights From the European Society of Cardiology, American Society of Nuclear Cardiology, and Heart Failure Society of America

Imaging Highlights From the European Society of Cardiology, American Society of Nuclear Cardiology, and Heart Failure Society of America

Highlights of the 2007 Scientific Sessions of the American Society of Nuclear Cardiology

Contact Info

Product

Resources

About